| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.47 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |